Next big milestone
Dicot intends to enter clinical trials in 2023. Read more about the way forward.
The Dicot panel of experts
Dicot's panel of experts helps in profiling LIB-1 and preparing it for market acceptance.
The Pharmaceutical Project
Dicot is in preclinical phase with the drug candidate LIB-01, a modern potency drug to better treat erectile dysfunction and premature ejaculation.
In a research collaboration with reputable Pelvipharm, the effect of the substance and future area of use will be clarified.Read More >
Toxicology determines the extent of a substance's possible side effects. Read more about Dicot's toxicology program here.Read More >